Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1970
|
| gptkbp:ATCCode |
M01CC01
|
| gptkbp:CASNumber |
52-67-5
|
| gptkbp:chemicalFormula |
C5H11NO2S
|
| gptkbp:contraindication |
pregnancy
renal impairment lupus erythematosus |
| gptkbp:drugClass |
chelating agent
disease-modifying antirheumatic drug |
| gptkbp:genericName |
gptkb:penicillamine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cuprimine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Bausch_Health
|
| gptkbp:mechanismOfAction |
chelates copper
reduces cystine stone formation |
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting proteinuria rash thrombocytopenia leukopenia |
| gptkbp:usedFor |
gptkb:Wilson's_disease
rheumatoid arthritis cystinuria |
| gptkbp:bfsParent |
gptkb:Valeant_Pharmaceuticals
|
| gptkbp:bfsLayer |
6
|